+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Scar Treatment Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 200 Pages
  • July 2024
  • Region: Global
  • Expert Market Research
  • ID: 5797993
The scar treatment market size was valued at USD 20.3 billion in 2023. It is expected to grow at a CAGR of 11.00% during the forecast period of 2024-2032, driven by increasing prevalence of skin conditions leading to scars. The market is experiencing robust growth and is expected to reach USD 51.4 billion by 2032.

Scar Treatment Market Analysis

The scar treatment market is poised for growth, driven by a combination of societal, technological, and healthcare factors. This analysis provides insights into the current state of the market, including drivers, challenges, and future opportunities.

Market Drivers

1. Increasing Prevalence of Skin Conditions: The rise in skin diseases and conditions leading to scars, such as acne, injuries, and surgeries, significantly drives the demand for effective scar treatment solutions.

2.Technological Advancements: Innovations in treatment technologies, especially in laser therapy, microdermabrasion, and injectables, offer more effective and less invasive scar treatment options, appealing to a broader base of consumers.

3. Growing Aesthetic Awareness: With increasing social media influence and a general shift towards maintaining an aesthetic appearance, individuals are more inclined to seek scar treatment to enhance their physical appearance and self-esteem.

4. Rising Disposable Income: Improved economic conditions globally have led to higher disposable incomes, making people more willing to invest in cosmetic treatments, including scar management.

Challenges

1. High Cost of Treatments: The cost of advanced scar treatment options remains prohibitive for a significant portion of the population, limiting market growth in less affluent regions.

2. Risk of Side Effects: Some scar treatment procedures carry the risk of side effects, such as skin discoloration and texture changes, which may deter potential users.

3. Limited Reimbursement Policies: The cosmetic nature of many scar treatments means they are often not covered by insurance policies, posing an additional barrier to market growth.

4. Cultural and Social Stigmas: In certain cultures, seeking cosmetic treatments, including for scar reduction, can be stigmatized, affecting market potential.

Future Opportunities

1. Emerging Markets: Developing countries, with their growing middle-class populations and increasing healthcare spending, present significant opportunities for market expansion.

2. Innovation in Products and Procedures: Continued research and development leading to more effective, safer, and cost-efficient scar treatment methods can broaden the market base.

3. Integration of Digital Technologies: The use of telemedicine, AI for personalized treatment plans, and mobile applications for monitoring progress can enhance patient experiences and outcomes.

4. Awareness and Education Campaigns: Initiatives by market players to educate potential customers about the safety and efficacy of modern scar treatments can help overcome hesitations related to side effects and cultural stigmas.

The scar treatment market is at a promising juncture, with the potential to expand significantly as it addresses current challenges and capitalizes on emerging opportunities. Market players who focus on innovation, accessibility, and patient education are likely to thrive in the evolving landscape.

Scar Treatment Market Trends

The scar treatment market is undergoing rapid transformations, driven by evolving consumer preferences, technological advancements, and shifts in the healthcare landscape. Understanding these trends is crucial for stakeholders looking to navigate the market effectively. Here are some insightful market trends shaping the future of scar treatment:

1. Shift Towards Non-invasive Treatments

There's a growing demand for non-invasive or minimally invasive scar treatment options. Treatments such as laser therapy, microdermabrasion, and topical products are gaining popularity over traditional surgical methods. This trend reflects the consumer's desire for treatments with shorter recovery times, lower risk of complications, and minimal discomfort.

2. Technological Innovations in Treatment Modalities

The market is witnessing significant technological innovations, particularly in laser treatments and regenerative medicine. Advanced lasers can now target various scar types with greater precision and less damage to surrounding tissues. Additionally, research into growth factors and stem cell therapy offers promising avenues for scar revision, potentially revolutionizing scar treatment approaches.

3. Increasing Personalisation of Scar Treatment Plans

Personalisation is becoming a key focus in the scar treatment market. Healthcare providers are increasingly adopting a tailored approach, considering the individual's scar type, skin type, and healing response. This personalized strategy enhances treatment effectiveness and patient satisfaction.

4. Rise of Home-based Scar Treatment Solutions

With advancements in over-the-counter (OTC) scar treatment products, there's a notable trend towards home-based care. Products such as silicone sheets, gels, and topical creams with active ingredients are becoming more sophisticated, offering consumers effective options for scar management from the comfort of their homes.

5. Growing Importance of Aesthetic Appearance

Societal emphasis on physical appearance and aesthetics continues to drive the scar treatment market. Social media and the desire to present a flawless image are pushing individuals towards seeking scar treatment solutions, thereby fueling market growth.

6. Expansion in Emerging Markets

Emerging economies represent significant growth opportunities for the scar treatment market. Increasing healthcare expenditure, growing awareness about available treatments, and rising disposable incomes in these regions are making scar treatments more accessible to a broader population.

7. Integration of AI and Digital Tools

Artificial Intelligence (AI) and digital tools are beginning to play a crucial role in scar treatment. From personalized treatment recommendations based on AI algorithms to the use of digital imaging for progress tracking, these technologies are enhancing the precision and effectiveness of scar management strategies.

8. Focus on Natural and Organic Ingredients

There's a noticeable trend towards the use of natural and organic ingredients in topical scar treatments. Consumers are increasingly looking for products free from synthetic chemicals, driven by a broader shift towards natural and sustainable health and beauty products.

These trends highlight the dynamic nature of the Scar Treatment Market. Stakeholders must stay attuned to these developments to effectively meet consumer needs, leverage new technologies and navigate the competitive landscape successfully.

Scar Treatment Market Segmentation

Market Breakup by Scar Type

  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Contracture Scars
  • Stretch Marks
The scar treatment market, spanning from 2017 to 2032, is segmented into atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. Market growth is primarily driven by increasing awareness and advancements in scar treatment technologies. Atrophic scars, resulting from acne and chickenpox, see high demand for treatments due to cosmetic concerns, indicating significant growth potential. Hypertrophic and keloid scars, often more challenging to treat, are witnessing innovations in laser therapy and silicone-based products, promising future expansion. Contracture scars, associated with burns, demand specialized treatment options, pushing the market towards more effective solutions. Stretch marks, common post-pregnancy or weight fluctuations, are seeing an uptick in non-invasive treatments, contributing to overall market growth. Together, these segments underscore the market's dynamic nature, driven by technological advancements, growing cosmetic consciousness, and the rising prevalence of scar-inducing conditions, positioning the scar treatment market on a trajectory of sustained growth through 2032.

Market Breakup by Product

  • Topical Products
  • Creams
  • Gels
  • Silicon Sheets
  • Others
  • Laser Products
  • CO2 Laser
  • Pulse-dyed Laser
  • Others
  • Injectable
  • Others
The scar treatment market is segmented into topical products, laser products, injectables, and others, each playing a crucial role in the market's growth from 2017 to 2032. Topical products, favored for their ease of use and accessibility, are anticipated to lead the market, driven by increasing consumer awareness and advancements in dermatological research. Laser products, renowned for their precision and effectiveness in minimizing scar appearance, are expected to witness substantial growth, fueled by technological innovations and growing preferences for minimally invasive treatments. Injectables, offering targeted treatments for various scar types, are poised for significant growth, supported by the rising demand for quick and effective scar remedies. The "Others" category, encompassing a variety of emerging scar treatment technologies, is set to contribute to the market's expansion, driven by ongoing research and a growing number of cosmetic procedures. Collectively, these segments are poised to drive the scar treatment market's growth, underpinned by increasing incidences of skin disorders, rising aesthetic consciousness, and advancements in scar treatment technologies.

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Others
The scar treatment market, from 2017 to 2032, is segmented into hospitals, ambulatory surgical centers, and other facilities, each playing a pivotal role in driving market growth. Hospitals, being primary care centers, have historically led the market due to their comprehensive treatment offerings and patient volume. Ambulatory surgical centers (ASCs) are projected to experience significant growth, attributed to the increasing preference for outpatient surgical treatments that are cost-effective and have shorter recovery times. The "others" segment, encompassing clinics and home care settings, is also poised for growth, driven by advancements in scar treatment products and technologies. Market drivers include rising incidences of skin disorders, growing awareness of aesthetic appearance, and technological advancements in scar treatment. These factors collectively contribute to the market's expansion, with each segment addressing unique patient needs and preferences, underscoring their role in overall market growth.

Market Breakup by Region

  • United States
  • EU-4 and United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India
The scar treatment market is experiencing significant growth across various regions, driven by an increasing prevalence of skin disorders, technological advancements in scar treatment, and a growing awareness of aesthetics. In the United States, the market benefits from advanced healthcare infrastructure and high expenditure on cosmetic procedures. The EU-4 and the United Kingdom see similar growth drivers, with additional support from favorable regulatory policies. Japan's market is propelled by its technological innovations and aging population seeking aesthetic treatments. India presents a rapidly growing segment, attributed to its increasing middle-class population and rising disposable income. Collectively, these regions are set to substantially contribute to the global market's expansion from 2017 to 2032, capitalizing on their unique market drivers to cater to the growing demand for effective scar treatment solutions.

Scar Treatment Market Competitive Landscape

The competitive landscape of the market is defined by the activities of leading companies. These key players are engaged in a variety of strategic initiatives including mergers and acquisitions, research and development efforts, product launches, and collaborations to strengthen their market positions and expand their product portfolios. Major companies in the market are as follows:
  • Alliance Pharma PLC
  • Perrigo Company Plc
  • Newmedical Technology Inc
  • Sonoma Pharmaceuticals, Inc.
  • HRA Pharma
  • Boston Scientific Corporation
  • CCA Industries, Inc.
  • Avita Medical, Inc
  • Smith& Nephew Plc
  • Shanghai Fosun Pharmaceuticals (Group) Co., Ltd.
  • Sientra, Inc
  • Molnlycke Health Care AB
  • Merz Pharma
  • POLYTECH Health & Aesthetics GmbH
  • CYNOSURE LUTRONIC

Key Questions Answered in the Report

  • What is the current and future performance of the scar treatment market?
  • What are the main challenges facing the scar treatment market?
  • What are the key drivers of the scar treatment market?
  • What emerging trends are shaping the future of the scar treatment market?
  • How are AI and digital tools enhancing the effectiveness of scar treatment strategies?
  • What factors are primarily driving the growth of the scar treatment market?
  • Why are ambulatory surgical centers projected to experience significant growth in the market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the scar treatment market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global scar treatment market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global scar treatment industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Scar Treatment Market Overview - 8 Major Markets
3.1 Scar Treatment Market Historical Value (2017-2023)
3.2 Scar Treatment Market Forecast Value (2024-2032)
4 Scar Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Scar Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Scar Type Success Rate
6 Scar Epidemiology Scenario and Forecast - 8 Major Markets
6.1 8MM Epidemiology Scenario Overview (2017-2032)
6.2 United States Scar Epidemiology Scenario and Forecast (2017-2032)
6.3 EU-4 and United Kingdom Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.1 Germany Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.2 France Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.3 Italy Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.4 Spain Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.5 United Kingdom Scar Epidemiology Scenario and Forecast (2017-2032)
6.4 Japan Scar Epidemiology Scenario and Forecast (2017-2032)
6.5 India Scar Epidemiology Scenario and Forecast (2017-2032)
7 Scar Treatment Market Landscape - 8 Major Markets
7.1 Scar Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Scar Treatment: Product Landscape
7.2.1 Analysis by Scar Type
7.2.2 Analysis by Product Type
7.2.3 Analysis by End User
8 Scar Challenges and Unmet Needs
8.1 Scar Type Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Scar Treatment
10 Scar Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Scar Treatment Market Segmentation (2017-2032) - 8 Major Markets
11.1 Scar Treatment Market (2017-2032) by Scar Type
11.1.1 Market Overview
11.1.2 Atrophic Scars
11.1.3 Hypertrophic and Keloid Scars
11.1.4 Contracture Scars
11.1.5 Stretch Marks
11.2 Scar Treatment Market (2017-2032) by Product
11.2.1 Market Overview
11.2.2 Topical Products
11.2.2.1 Creams
11.2.2.2 Gels
11.2.2.3 Silicon Sheets
11.2.2.4 Others
11.2.3 Laser Products
11.2.3.1 CO2 Laser
11.2.3.2 Pulse-dyed Laser
11.2.3.3 Others
11.2.4 Injectable
11.2.5 Others
11.3 Scar Treatment Market (2017-2032) by End User
11.3.1 Hospitals
11.3.2 Ambulatory Surgical Centers
11.3.3 Others
11.4 Scar Treatment Market (2017-2032) by Region
11.4.1 Market Overview
11.4.2 United States
11.4.3 EU-4 and the United Kingdom
11.4.3.1 Germany
11.4.3.2 France
11.4.3.3 Italy
11.4.3.4 Spain
11.4.3.5 United Kingdom
11.4.4 Japan
11.4.5 India
12 United States Scar Treatment Market (2017-2032)
12.1 United States Scar Treatment Market Historical Value (2017-2023)
12.2 United States Scar Treatment Market Forecast Value (2024-2032)
12.3 United States Scar Treatment Market (2017-2032) by Scar Type
12.3.1 Market Overview
12.3.2 Atrophic Scars
12.3.3 Hypertrophic and Keloid Scars
12.3.4 Contracture Scars
12.3.5 Stretch Marks
12.4 United States Scar Treatment Market (2017-2032) by Product
12.4.1 Market Overview
12.4.2 Topical Products
12.4.2.1 Creams
12.4.2.2 Gels
12.4.2.3 Silicon Sheets
12.4.2.4 Others
12.4.3 Laser Products
12.4.3.1 CO2 Laser
12.4.3.2 Pulse-dyed Laser
12.4.3.3 Others
12.4.4 Injectable
12.4.5 Others
13 EU-4 and United Kingdom Scar Treatment Market (2017-2032)
13.1 EU-4 and United Kingdom Scar Treatment Market Historical Value (2017-2023)
13.2 EU-4 and United Kingdom Scar Treatment Market Forecast Value (2024-2032)
13.3 EU-4 and United Kingdom Scar Treatment Market (2017-2032) by Scar Type
13.3.1 Market Overview
13.3.2 Atrophic Scars
13.3.3 Hypertrophic and Keloid Scars
13.3.4 Contracture Scars
13.3.5 Stretch Marks
13.4 EU-4 and United Kingdom Scar Treatment Market (2017-2032) by Product
13.4.1 Market Overview
13.4.2 Topical Products
13.4.2.1 Creams
13.4.2.2 Gels
13.4.2.3 Silicon Sheets
13.4.2.4 Others
13.4.3 Laser Products
13.4.3.1 CO2 Laser
13.4.3.2 Pulse-dyed Laser
13.4.3.3 Others
13.4.4 Injectable
13.4.5 Others
14 Japan Scar Treatment Market
14.1 Japan Scar Treatment Market Historical Value (2017-2023)
14.2 Japan Scar Treatment Market Forecast Value (2024-2032)
14.3 Japan Scar Treatment Market (2017-2032) by Scar Type
14.3.1 Market Overview
14.3.2 Atrophic Scars
14.3.3 Hypertrophic and Keloid Scars
14.3.4 Contracture Scars
14.3.5 Stretch Marks
14.4 Japan Scar Treatment Market (2017-2032) by Product
14.4.1 Market Overview
14.4.2 Topical Products
14.4.2.1 Creams
14.4.2.2 Gels
14.4.2.3 Silicon Sheets
14.4.2.4 Others
14.4.3 Laser Products
14.4.3.1 CO2 Laser
14.4.3.2 Pulse-dyed Laser
14.4.3.3 Others
14.4.4 Injectable
14.4.5 Others
15 India Scar Treatment Market
15.1 India Scar Treatment Market (2017-2032) Historical Value (2017-2023)
15.2 India Scar Treatment Market (2017-2032) Forecast Value (2024-2032)
15.3 India Scar Treatment Market (2017-2032) by Scar Type
15.3.1 Market Overview
15.3.2 Atrophic Scars
15.3.3 Hypertrophic and Keloid Scars
15.3.4 Contracture Scars
15.3.5 Stretch Marks
15.4 India Scar Treatment Market (2017-2032) by Product
15.4.1 Market Overview
15.4.2 Topical Products
15.4.2.1 Creams
15.4.2.2 Gels
15.4.2.3 Silicon Sheets
15.4.2.4 Others
15.4.3 Laser Products
15.4.3.1 CO2 Laser
15.4.3.2 Pulse-dyed Laser
15.4.3.3 Others
15.4.4 Injectable
15.4.5 Others
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 Japan PMDA
16.1.4 India CDSCO
16.1.5 Others
17 Patent Analysis
17.1 Analysis by Drug Type of Patent
17.2 Analysis by Publication Year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by Year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding and Investment Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Drug Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Drug Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Supplier Landscape
22.1 Alliance Pharma PLC
22.1.1 Financial Analysis
22.1.2 Product Portfolio
22.1.3 Demographic Reach and Achievements
22.1.4 Mergers and Acquisitions
22.1.5 Certifications
22.2 Perrigo Company plc
22.2.1 Financial Analysis
22.2.2 Product Portfolio
22.2.3 Demographic Reach and Achievements
22.2.4 Mergers and Acquisitions
22.2.5 Certifications
22.3 Newmedical Technology Inc.
22.3.1 Financial Analysis
22.3.2 Product Portfolio
22.3.3 Demographic Reach and Achievements
22.3.4 Mergers and Acquisitions
22.3.5 Certifications
22.4 Sonoma Pharmaceuticals, Inc.
22.4.1 Financial Analysis
22.4.2 Product Portfolio
22.4.3 Demographic Reach and Achievements
22.4.4 Mergers and Acquisitions
22.4.5 Certifications
22.5 HRA Pharma
22.5.1 Financial Analysis
22.5.2 Product Portfolio
22.5.3 Demographic Reach and Achievements
22.5.4 Mergers and Acquisitions
22.5.5 Certifications
22.6 Boston Scientific Corporation
22.6.1 Financial Analysis
22.6.2 Product Portfolio
22.6.3 Demographic Reach and Achievements
22.6.4 Mergers and Acquisitions
22.6.5 Certifications
22.7 CCA Industries, Inc.
22.7.1 Financial Analysis
22.7.2 Product Portfolio
22.7.3 Demographic Reach and Achievements
22.7.4 Mergers and Acquisitions
22.7.5 Certifications
22.8 Avita Medical,Inc.
22.8.1 Financial Analysis
22.8.2 Product Portfolio
22.8.3 Demographic Reach and Achievements
22.8.4 Mergers and Acquisitions
22.8.5 Certifications
22.9 Smith & Nephew PLC
22.9.1 Financial Analysis
22.9.2 Product Portfolio
22.9.3 Demographic Reach and Achievements
22.9.4 Mergers and Acquisitions
22.9.5 Certifications
22.10 Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
22.10.1 Financial Analysis
22.10.2 Product Portfolio
22.10.3 Demographic Reach and Achievements
22.10.4 Mergers and Acquisitions
22.10.5 Certifications
22.11 Sientra, Inc.
22.11.1 Financial Analysis
22.11.2 Product Portfolio
22.11.3 Demographic Reach and Achievements
22.11.4 Mergers and Acquisitions
22.11.5 Certifications
22.12 Mölnlycke Health Care AB
22.12.1 Financial Analysis
22.12.2 Product Portfolio
22.12.3 Demographic Reach and Achievements
22.12.4 Mergers and Acquisitions
22.12.5 Certifications
22.13 Merz Pharma
22.13.1 Financial Analysis
22.13.2 Product Portfolio
22.13.3 Demographic Reach and Achievements
22.13.4 Mergers and Acquisitions
22.13.5 Certifications
22.14 POLYTECH Health & Aesthetics GmbH
22.14.1 Financial Analysis
22.14.2 Product Portfolio
22.14.3 Demographic Reach and Achievements
22.14.4 Mergers and Acquisitions
22.14.5 Certifications
22.15 CYNOSURE LUTRONIC
22.15.1 Financial Analysis
22.15.2 Product Portfolio
22.15.3 Demographic Reach and Achievements
22.15.4 Mergers and Acquisitions
22.15.5 Certifications
23 Scar Treatment Market - Distribution Model (Additional Insight)
23.1 Overview
23.2 Potential Distributors
23.3 Key Parameters for Distribution Partner Assessment
24 Key Opinion Leaders (KOL) Insights (Additional Insight)
25 Company Competitiveness Analysis (Additional Insight)
25.1 Very Small Companies
25.2 Small Companies
25.3 Mid-Sized Companies
25.4 Large Companies
25.5 Very Large Companies
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.

Companies Mentioned

  • Alliance Pharma PLC
  • Perrigo Company plc
  • Newmedical Technology Inc.
  • Sonoma Pharmaceuticals, Inc.
  • HRA Pharma
  • Boston Scientific Corporation
  • CCA Industries, Inc.
  • Avita Medical,Inc.
  • Smith & Nephew PLC
  • Shanghai Fosun Pharmaceutical Group Co., Ltd.
  • Sientra, Inc.
  • Mölnlycke Health Care AB
  • Merz Pharma
  • POLYTECH Health & Aesthetics GmbH
  • CYNOSURE LUTRONIC

Methodology

Loading
LOADING...

Table Information